Peripheral Interventions Market to hit $ 10.5 billion by 2025: Global Market Insights, Inc.

Global Peripheral Interventions Market is expected to achieve around 9% CAGR from 2019 to 2025, supported by increasing patient size suffering from neurovascular and kidney disorders.

Selbyville, Delaware, Oct. 03, 2019 (GLOBE NEWSWIRE) --

The Peripheral Interventions Market revenue is projected to cross USD 10.5 million by 2025; according to a new research report by Global Market Insights, Inc. Growing technological advancements and innovations in peripheral interventions devices, leading to greater procedural success rate will stimulate the industry growth. With growing inclination towards minimally invasive procedures and advancement, the peripheral vascular interventions will witness robust demand in the upcoming years.

Growing incidence of various cardiac and vascular disorders will stimulate the global peripheral interventions market growth in the forthcoming years. Vascular and cardiac disorders are the most common problems among geriatric population and middle-aged people. As per the Global Heart Foundation, approximately 7.4 million people living in the UK suffer from heart and circulatory disease. Moreover, being one of the foremost causes of hypertension and several arterial disorders, it will create significant demand for diagnosis and treatment of peripheral interventional disorders. Rising number of vascular disorder patients will increase the adoption of peripheral vascular devices, thereby increasing market size from 2019 to 2025.

Request for a sample of this research report @

Balloon catheter technology for removing plaque is anticipated to drive segmental revenue owing to rising adoption of minimally invasive and non-invasive surgical procedures. Technological breakthroughs coupled with expanding balloon interventional procedure is estimated to increase its adoption for the treatment of vascular disease patients. Thus, rapid demand for balloon technology for peripheral interventions will spur the market growth over the analysis period.

‘Others’ segment including treatment of several diseases such as neurovascular disorders, liver cirrhosis, hernia, and kidney disorders is forecasted to progress at 8.4% CAGR from 2019 to 2025. High growth can be attributed to rising prevalence of neurological disorders. Moreover, increasing number of patients suffering from neurological disorders and risk factors associated with comorbidities will impel the adoption of peripheral interventions devices, further impacting market growth over the upcoming years.

Browse key industry insights spread across 180 pages with 297 market data tables & 8 figures & charts from the report, “Peripheral Interventions Market Size By Product (Catheters, Sheath, Stents {Bare Metal Stents, Drug-eluting Stents}, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters) By Application (Vascular Diseases {Peripheral Artery Disease, Venous Thrombosis, Atherosclerosis, Varicose Veins}, Cancer) By End-use (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centers),  Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Price Trends, Application Potential, Competitive Market Share & Forecast, 2019 – 2025”in detail along with the table of contents:

Ambulatory surgical centers will witness 8.8% CAGR over the analysis period. Robust segmental growth can be attributed to increasing preference for short-duration procedures coupled with rising number of ambulatory surgical centers. Growing healthcare expenditure in developing nations will continue to provide better and effective treatment options, fueling adoption of peripheral vascular interventions devices in outpatient facilities.

Canada peripheral interventions market will witness 8.8% CAGR due to slowly increasing awareness regarding diagnosis of peripheral artery disease. Increasing consumer awareness related to vascular diseases and interventional oncology as well as presence of specialized healthcare facilities will contribute to the revenue growth. Furthermore, increasing government initiatives will be the major factor supporting industry development. Additionally, the emergence of major global manufacturers across Canada will boost industry growth in the upcoming years.

Growing market opportunity for the treatment of deep vein thrombosis and oncology will encourage more companies to enter the global peripheral interventions market. Key players operating in the market are Abbott, AgioDynamics Inc., Boston Scientific Corporation, Cook Group, W.L. Gore & Associates, C.R. Bard and Teleflex, among others. These industry players have adopted strategic initiatives such as new product launches and collaborations to capture higher profits and lucrative market share. In April 2018, Vascutek Terumo merged with Bolton Medical, to accelerate expansion of its vascular graft business. The merger helped to enhance Terumo's existing product portfolio in the global stent graft market.   

Make an inquiry for purchasing this report @

Browse Related Reports:

Dialysis Market Statistics 2024: U.S. market dominated North America region and was valued at USD 24 billion revenue in 2017 and the high revenue can be attributed to the growing geriatric population suffering from various renal diseases. Prominent industry players operational in the market include Asahi Kasei Corporation, B. Braun Melsungen, Baxter International, Fresenius Medical Care, JMS, Kawasumi Laboratories, Medtronic, Nikkiso, Nipro, Toray, DaVita, U.S. Renal Care, Satellite Healthcare and Rogosin Institute.

Stent Market Projections 2019-2025: The U.S. market accounted for more than 30% market share in 2018 and is estimated to follow similar trend and lead the industry at a global level over the coming years. Some of the key industry players operating in the global market are Medtronic, Boston Scientific, Abbott Laboratories, Terumo, C R Bard, B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Meril Life Sciences, MicroPort Scientific Corporation and Elixir Medical Corporation.

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Contact Data